Evidence map›Paper›PMID 34651466›Full record

ArticleJournal of extracellular vesicles2021

Urinary extracellular vesicles: Assessment of pre-analytical variables and development of a quality control with focus on transcriptomic biomarker research.

Karina Barreiro, Om Prakash Dwivedi, Sami Valkonen, Per-Henrik Groop, Tiinamaija Tuomi, Harry Holthofer, Antti Rannikko, Marjo Yliperttula, Pia Siljander, Saara Laitinen and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 5 countries.

Karina BarreiroInstitute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Om Prakash DwivediInstitute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Sami ValkonenEV Group, Molecular and Integrative Biosciences Research Program, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.
Per-Henrik GroopFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Tiinamaija TuomiInstitute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Harry HolthoferInstitute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Antti RannikkoDepartment of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Marjo YliperttulaDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Pia SiljanderEV Group, Molecular and Integrative Biosciences Research Program, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.
Saara LaitinenResearch and Development, Finnish Red Cross Blood Service, Helsinki, Finland.
Elina SerkkolaOrion Pharma, Orion Corporation, Espoo, Finland.
Taija Af HällströmAstraZeneca, Espoo, Finland.
Carol ForsblomInstitute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Leif GroopInstitute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
Maija PuhkaInstitute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIAstraZeneca (United Kingdom) · GBFinnish Red Cross · FIOrion Corporation (Finland) · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary extracellular vesicles (uEV) are a topical source of non-invasive biomarkers for health and diseases of the urogenital system. However, several challenges have become evident in the standardization of uEV pipelines from collection of urine to biomarker analysis. Here, we studied the effect of pre-analytical variables and developed means of quality control for uEV isolates to be used in transcriptomic biomarker research. We included urine samples from healthy controls and individuals with type 1 or type 2 diabetes and normo-, micro- or macroalbuminuria and isolated uEV by ultracentrifugation. We studied the effect of storage temperature (-20°C vs. -80°C), time (up to 4 years) and storage format (urine or isolated uEV) on quality of uEV by nanoparticle tracking analysis, electron microscopy, Western blotting and qPCR. Urinary EV RNA was compared in terms of quantity, quality, and by mRNA or miRNA sequencing. To study the stability of miRNA levels in samples isolated by different methods, we created and tested a list of miRNAs commonly enriched in uEV isolates. uEV and their transcriptome were preserved in urine or as isolated uEV even after long-term storage at -80°C. However, storage at -20°C degraded particularly the GC-rich part of the transcriptome and EV protein markers. Transcriptome was preserved in RNA samples extracted with and without DNAse, but read distributions still showed some differences in e.g. intergenic and intronic reads. MiRNAs commonly enriched in uEV isolates were stable and concordant between different EV isolation methods. Analysis of never frozen uEV helped to identify surface characteristics of particles by EM. In addition to uEV, qPCR assays demonstrated that uEV isolates commonly contained polyoma viruses. Based on our results, we present recommendations how to store and handle uEV isolates for transcriptomics studies that may help to expedite standardization of the EV biomarker field.

Indexed as

AdultBiomarkersCase-Control StudiesDiabetes MellitusExtracellular VesiclesHumansQuality ControlTranscriptomeBiomarkersbiomarkersDNAsemicroRNAmRNAstorage temperaturestorage timetranscriptomicsurinary exosomesurinary extracellular vesiclesvirus

Identifiers

PMID34651466
PMCPMC8517090
OpenAlexW3205173994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.